GlassScriptPhysician profile
Nesher G Asner
NPI 1750363651
$1,191.44
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $828 · 2020: $302 · 2021: $61.60.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $170.30 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $163.40 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $151.52 | 2019-2020 | |
| Lemaitre Vascular, INC. | $131.83 | 2019 | |
| Lilly USA, LLC | $98.68 | 2019-2021 | |
| Boston Scientific Corporation | $97.67 | 2019 | |
| Bausch Health US, LLC | $41.71 | 2019-2020 | |
| Si-Bone, INC. | $38.53 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $36.98 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $32.11 | 2019 | |
| Assertio Therapeutics, INC. | $29.29 | 2019-2020 | |
| Promius Pharma LLC | $25.32 | 2019 | |
| Arbor Pharmaceuticals, INC. | $22.97 | 2019 | |
| Livanova USA, INC. | $21.82 | 2019 | |
| Tersera Therapeutics LLC | $21.30 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $21.12 | 2020 | |
| Surgalign Spine Technologies, INC. | $17.48 | 2020 | |
| Abbvie INC. | $17.23 | 2021 | |
| Allergan, INC. | $14.59 | 2019 | |
| Amneal Pharmaceuticals LLC | $14.42 | 2020 | |
| Pernix Therapeutics Holdings, INC. | $12.09 | 2019 | |
| Upsher-Smith Laboratories LLC | $11.08 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nesher Asner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.